Home Categories API Maraviroc
A5516512

Maraviroc , 98% , 376348-65-1

Synonym(s):
4,4-Difluoro-N-[(1S)-3-[(3-exo)-3-[3-methyl-5-(1-methylethyl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]oct-8-yl]-1-phenylpropyl]cyclohexanecarboxamide;UK-427857

CAS NO.:376348-65-1

Empirical Formula: C29H41F2N5O

Molecular Weight: 513.68

MDL number: MFCD09953791

EINECS: 609-456-0

Pack Size Price Stock Quantity
5MG RMB359.20 In Stock
25MG RMB1439.20 In Stock
100MG RMB4169.60 In Stock
others     Enquire
Update time: 2022-07-08

PRODUCT Properties

Melting point: 79-81°C
Density  1.29±0.1 g/cm3(Predicted)
storage temp.  room temp
solubility  DMSO: >30mg/mL
pka 7.3(at 25℃)
form  white powder
color  White
optical activity [α]-15/D
Stability: Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months.
InChIKey GSNHKUDZZFZSJB-RWJISDSDNA-N
SMILES C(N1[C@@H]2CC[C@H]1C[C@H](N1C(=NN=C1C(C)C)C)C2)C[C@@H](C1C=CC=CC=1)NC(C1CCC(F)(F)CC1)=O |&1:2,5,7,19,r|
CAS DataBase Reference 376348-65-1(CAS DataBase Reference)

Description and Uses

Maraviroc is the first CCR5 receptor antagonist that has been developed and launched for the treatment of HIV-1. Maraviroc binds in a slowly reversible, allosteric manner to CCR5, which is one of two principle chemokine co-receptors for viral entry into the host cell, the other being CXCR4. Binding of maraviroc to CCR5 induces conformational changes within the chemokine receptor, thereby preventing CCR5 binding to the viral gp120 protein and the ultimate CCR5- mediated virus-cell fusion that is a prerequisite for HIV invasion. Maraviroc, with its unique mechanism of action as a fusion inhibitor, joins the greater than 20 marketed antiretrovirals, including nucleotide reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), and PIs. It is approved for use in combination with these other antiretroviral drugs in adult patients with R5-tropic HIV-1 infection (but not X4 or dual/mixed tropic HIV-1).

Maraviroc is a potent, non-competitive CCR5 receptor antagonist; inhibits binding of HIV viral coat protein gp120. Antiviral.

Safety

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H302
Precautionary statements  P280-P305+P351+P338
Hazard Codes  Xn
Risk Statements  48/22
Safety Statements  22-36
WGK Germany  1
Hazardous Substances Data 376348-65-1(Hazardous Substances Data)

RELATED PRODUCTS